VC-backed Therachon buys GLyPharma

Therachon has acquired Montreal-based GLyPharma Therapeutic Inc, a developer of drugs for short bowel syndrome and other rare gastrointestinal diseases. No financial terms were disclosed. Therachon is backed by Novo Holdings, Cowen Healthcare Investments, Pfizer Ventures, Tekla Capital Management LLC, Versant Ventures, OrbiMed, Bpifrance and Inserm Transfert Initiative.

DealsNorth AmericaUSHealthcareBriefs